期刊文献+

胃癌转移复发的非手术治疗

下载PDF
导出
摘要 胃癌是常见的恶性肿瘤之一,其全球发病率在恶性肿瘤中排名第4位。我国是胃癌高发国家,全球每年新发胃癌病例中46.8%发生在我国。由于早期诊断率低,我国大部分胃癌病人就诊时已是中、晚期。根治性手术是治疗胃癌的主要手段,但除了T1期胃癌病人根治术后可有很长的生存时间外,即使接受D2根治手术,进展期胃癌病人仍有40%以上发生复发[1-2]。对于转移复发的病人,推荐姑息治疗。
作者 李伟 刘天舒
出处 《外科理论与实践》 2015年第1期13-17,共5页 Journal of Surgery Concepts & Practice
  • 相关文献

参考文献34

  • 1Nakajima T, Nashimoto A, Kitamura M, et al. Adju-vant mitomycin and fluorouracil followed by oral uracilplus tegafur in serosa-negative gastric cancer: a ran-domised trial. Gastric Cancer Surgical Study Group [J].Lancet, 1999,354(9175):273-277.
  • 2Bang YJ, Kim YW, Yang HK, et al. Adjuvantcapecitabine and oxaliplatin for gastric cancer after D2gastrectomy (CLASSIC): a phase 3 open-label, randomisedcontrolled tnal[J]. Lancet,2012,379(9813);315-321.
  • 3Wu CW, Lo SS, Shen KH, et al. Incidence and factorsassociated with recurrence patterns after intended cura-tive surgery for gastric cancer[J]. World J Surg,2003,27(2):153-158.
  • 4Fujimura T, Ohta T, Kitagawa H, et al. Trypsinogen ex-pression and early detection for peritoneal disseminationin gastric cancer[J]. J Surg Oncol, 1998,69(2):71-75.
  • 5Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvantchemotherapy for gastric cancer with S-l,an oral fluo-ropyrimidine[J]. N Engl J Med,2007,357(18):1810-1820.
  • 6Bentrem D, Wilton A, Mazumdar M, et al. The value ofperitoneal cytology as a preoperative predictor in patientswith gastric carcinoma undergoing a curative resection[J].Ann Surg Oncol,2005,12(5):347-353.
  • 7Songun I,Putter H, Kranenbarg EM, et al. Surgical treat-ment of gastric cancer: 15-year follow-up results of therandomised nationwide Dutch D1D2 trial[J]. Lancet Oncol,2010,11(5):439-449.
  • 8Wagner AD, Unverzagt S,Grothe W, et al. Chemotherapyfor advanved gastric cancer [J/OL]. Cochrane DatabaseSyst Rev, 2010-03-17 [2014-1 l-21].http://www.ncbi.nlm.nih.gov/pubmed/20238327/.
  • 9van Cutsem E,Moiseyenko VM, Tjulandin S,et al. PhaseID study of docetaxel and cisplatin plus fluorouracilcompared with cisplatin and fluorouracil as first-line the-rapy for advanced gastric cancer: a report of the V325Study Group[J]. J Clin Oncol,2006,24(31):4991 -4997.
  • 10Cunningham D,Starling N, Rao S,et al. Capecitabineand oxaliplatin for advanced esophagogastric cancer[J]. NEngl J Med,2008,358(1):36-46.

二级参考文献18

  • 1Suma L Sangisetty,Thomas J Miner.恶意的腹水: 预示的因素, pathophysiology 和治疗学的措施的评论[J].World Journal of Gastrointestinal Surgery,2012,4(4):87-95. 被引量:45
  • 2蔡艳军,郑大勇,罗荣城,陈锦章,李爱民,席箐乐,丁雪梅.Avastin联合顺铂对VEGF高表达的荷卵巢癌裸鼠腹水的抑制作用[J].南方医科大学学报,2007,27(5):647-649. 被引量:9
  • 3朱慰祺 沈铭昌 廉养德 等.胃癌[A].见:汤钊猷主编.现代肿瘤学:第2版[C].上海:上海医科大学出版社,2000.710~712.
  • 4Ishigami H, Kitayama J, Kaisaki S,et al. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis [J]. AnnOncol, 2010, 21(1): 67-70.
  • 5Akutagawa N ,Nishikama A ,Iwasaki M,et al. Expression of vascular endothelial growth factor and E cadherin in human o varian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse aseites model [J].Jpn J Cancer Res,2002,93 (6) :644-651.
  • 6高汝贵,李光.消化道肿瘤[M]//刘泰福.现代放射肿瘤学.上海:复旦大学出版社,2001:381.
  • 7Smalley SR, Gunderson L, Tepper J, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys, 2002, 52:283-293.
  • 8Minsky BD. The role of radiation theraphy in gastric carcinoma. Semin Oncol, 1996, 23:390-396.
  • 9Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failute in a re-operation series(second or symptomatic looks). Clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys, 1982, 8 ; 1-11.
  • 10Hennans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomize trail. J Clin Oncol, 1993, 11:1441.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部